[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9220 Introduced in House (IH)]

<DOC>






118th CONGRESS
  2d Session
                                H. R. 9220

To amend the Office of National Drug Control Policy Reauthorization Act 
of 2006 to modify the authority of the Office of National Drug Control 
  Policy with respect to the World Anti-Doping Agency, and for other 
                               purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             July 30, 2024

   Mr. Moolenaar (for himself and Mr. Krishnamoorthi) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
To amend the Office of National Drug Control Policy Reauthorization Act 
of 2006 to modify the authority of the Office of National Drug Control 
  Policy with respect to the World Anti-Doping Agency, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Restoring Confidence in the World 
Anti-Doping Agency Act of 2024''.

SEC. 2. AUTHORITY OF NATIONAL DRUG CONTROL POLICY WITH RESPECT TO THE 
              WORLD ANTI-DOPING AGENCY.

    Section 701 of the Office of National Drug Control Policy 
Reauthorization Act of 2006 (21 U.S.C. 2001) is amended--
            (1) in subsection (a)--
                    (A) by amending paragraph (1) to read as follows:
            ``(1) United states olympic and paralympic committee.--The 
        term `United States Olympic and Paralympic Committee' means the 
        organization established by chapter 2205 of title 36, United 
        States Code.'';
                    (B) in paragraph (3), by striking ``(36 U.S.C. 
                22501(b)(1))'' and inserting ``(36 U.S.C. 
                220501(b)(1))'';
                    (C) by redesignating paragraphs (1) and (3) as 
                paragraphs (4) and (1), respectively, and moving the 
                paragraphs so as to appear in numeric order; and
                    (D) by inserting after paragraph (2) the following:
            ``(3) Independent athlete.--The term `independent athlete' 
        means an Olympic or Paralympic athlete who does not serve, in 
        any capacity--
                    ``(A) on the International Olympic Committee;
                    ``(B) on the International Paralympic Committee;
                    ``(C) at an international sports federation 
                recognized by the International Olympic Committee or 
                the International Paralympic Committee;
                    ``(D) on the United States Olympic and Paralympic 
                Committee; or
                    ``(E) at the World Anti-Doping Agency.'';
            (2) in subsection (b)--
                    (A) by striking ``United States Olympic Committee'' 
                each place it appears and inserting ``United States 
                Olympic and Paralympic Committee'';
                    (B) in paragraph (5), by striking the period at the 
                end and inserting ``; and''; and
                    (C) by adding at the end the following:
            ``(6) carry out responsibilities with respect to the World 
        Anti-Doping Agency, as described in subsection (d).''; and
            (3) by adding at the end the following:
    ``(d) Authority With Respect to the World Anti-Doping Agency.--
            ``(1) In general.--The Office of National Drug Control 
        Policy, in consultation with the United States Anti-Doping 
        Agency, the United States Olympic and Paralympic Committee, and 
        the Team USA Athletes' Commission, shall--
                    ``(A) use all available tools to ensure that--
                            ``(i) the World Anti-Doping Agency has a 
                        credible and independent governance model that 
                        provides for fair representation of the United 
                        States;
                            ``(ii) the World Anti-Doping Agency fully 
                        implements all governance reforms, including a 
                        proper conflict-of-interest policy for all 
                        members of the Executive Committee, the 
                        Foundation Board, and all relevant expert 
                        advisory groups, standing committees, permanent 
                        special committees, and working groups of the 
                        World Anti-Doping Agency; and
                            ``(iii) independent athletes from the 
                        United States and other democratic countries, 
                        or representatives of such athletes, have 
                        decision-making roles on the Executive 
                        Committee and the Foundation Board, and in all 
                        relevant expert advisory groups, standing 
                        committees, permanent special committees, and 
                        working groups, of the World Anti-Doping 
                        Agency;
                    ``(B) demonstrate leadership within the global 
                community;
                    ``(C) have strict standards that work toward 
                countering doping in every form, including by 
                countering systemic fraud through doping involving--
                            ``(i) governmental law enforcement, 
                        intelligence, or anti-doping institutions;
                            ``(ii) sporting organizations; or
                            ``(iii) athlete support personnel; and
                    ``(D) work collaboratively with democratic 
                countries.
            ``(2) Determination.--
                    ``(A) In general.--Not later than 90 days after the 
                date of the enactment of this subsection, the Office of 
                National Drug Control Policy, in consultation with the 
                United States Anti-Doping Agency, the United States 
                Olympic and Paralympic Committee, and the Team USA 
                Athletes' Commission, shall make a determination as to 
                whether the World Anti-Doping Agency--
                            ``(i) has a credible and independent 
                        governance model that provides for fair 
                        representation of the United States;
                            ``(ii) fully implements all governance 
                        reforms, including a proper conflict-of-
                        interest policy described in paragraph 
                        (1)(A)(ii); and
                            ``(iii) allows independent athletes from 
                        the United States and other democratic 
                        countries, or representatives of such athletes, 
                        to have decision-making roles on the Executive 
                        Committee and the Foundation Board, and in all 
                        relevant expert advisory groups, standing 
                        committees, permanent special committees, and 
                        working groups, of the World Anti-Doping 
                        Agency.
                    ``(B) Accountability.--In the case of a 
                determination under subparagraph (A) that the World 
                Anti-Doping Agency does not have such a governance 
                model, has not fully implemented such governance 
                reforms, or has not allowed decision-making roles 
                described in clause (iii) of that subparagraph, the 
                Office of National Drug Control Policy, in consultation 
                with the United States Anti-Doping Agency, the United 
                States Olympic and Paralympic Committee, and the Team 
                USA Athletes' Commission, shall--
                            ``(i) use all available tools to ensure 
                        that the United States has fair representation 
                        in the World Anti-Doping Agency, including--
                                    ``(I) on the Executive Committee;
                                    ``(II) on the Foundation Board; and
                                    ``(III) in all relevant expert 
                                advisory groups, standing committees, 
                                permanent special committees, and 
                                working groups of the World Anti-Doping 
                                Agency; and
                            ``(ii) not later than 180 days after the 
                        date on which the determination under 
                        subparagraph (A) is made, issue a report that 
                        describes the barriers to participation and 
                        fair representation of the United States on the 
                        Executive Committee, the Foundation Board, and 
                        all relevant expert advisory groups, standing 
                        committees, permanent special committees, and 
                        working groups of the World Anti-Doping Agency.
            ``(3) Voluntary nonpayment of dues.--
                    ``(A) In general.--In the case of a determination 
                under paragraph (2)(A) that the World Anti-Doping 
                Agency does not have a governance model that provides 
                for fair representation of the United States, has not 
                fully implemented governance reforms, or has not 
                allowed decision-making roles described in clause (iii) 
                of that subparagraph, the Office of National Drug 
                Control Policy, in consultation with the appropriate 
                committees of Congress, may voluntarily withhold up to 
                the full amount of membership dues to the World Anti-
                Doping Agency.
                    ``(B) Appropriate committees of congress defined.--
                In this paragraph, the term `appropriate committees of 
                Congress' means--
                            ``(i) the Subcommittee on Consumer 
                        Protection, Product Safety, and Data Security 
                        of the Committee on Commerce, Science, and 
                        Transportation of the Senate (or a successor 
                        subcommittee);
                            ``(ii) the Subcommittee on Financial 
                        Services and General Government of the 
                        Committee on Appropriations of the Senate (or a 
                        successor subcommittee);
                            ``(iii) the Subcommittee on Oversight and 
                        Investigations of the Committee on Energy and 
                        Commerce of the House of Representatives (or a 
                        successor subcommittee); and
                            ``(iv) the Subcommittee on Financial 
                        Services and General Government of the 
                        Committee on Appropriations of the House of 
                        Representatives (or a successor subcommittee).
            ``(4) Spending plan.--Not later than 30 days before the 
        Office of National Drug Control Policy obligates funds to the 
        World Anti-Doping Agency, the Office of National Drug Control 
        Policy shall submit to the Committee on Appropriations of the 
        Senate and the Committee on Appropriations of the House of 
        Representatives a spending plan and explanation of proposed 
        uses of such funds.''.
                                 <all>